Tag: Relyvrio

According to landmark clinical trials, Riluzole was associated with a statistically significant prolongation of survival for patients with Amyotrophic Lateral Sclerosis (ALS). This makes it the only widely available drug that prolongs survival in patients with ALS, a progressive neurodegenerative disease.

In the United States, approximately 2% of ALS cases are the genetic form known as SOD1-ALS [1.8.3]. For these patients, a targeted therapy approved in 2023 represents a major advancement. So, what is the newest drug for ALS, and how does it fit into the evolving landscape of treatment?

Drug identification by name alone can be highly misleading, as informal terms often cause confusion, especially with a search like 'What is a Rio pill?'. This phrase does not correspond to a single, officially recognized medication but can refer to several different pills or substances.